Purchase Order W81K0225PA014
Award Date
3/14/25
Potential Completion Date
3/22/25
Potential Value
$19K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Sirtex Medical Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Tacoma, WA 98431, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm-fixed-price purchase order was awarded to Sirtex Medical Inc., a for-profit medical device company, by the Defense Health Agency. The contract is for the supply of SIR-Spheres Y-90 radioactive microspheres, which are used in interventional radiology procedures to treat liver tumors and metastatic disease through internal radiation therapy. The contract has a potential value of $17,750.00 and a completion date of August 1, 2022. The contract does not have a set-aside designation. Sirtex...
This is a firm fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Sirtex Medical Inc., a for-profit medical device company, to provide SIR-Spheres Y-90 resin microspheres, a targeted radiation therapy used to treat inoperable primary and metastatic liver tumors, as well as metastatic colorectal cancer to the liver. The contract has a ceiling value of $17,372.00 and does not have a set-aside designation. Sirtex Medical Inc. has a long history of providing these...
This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Sirtex Medical Inc., a global healthcare company specializing in cancer therapies. The $90,240.00 contract is for the delivery of SIRTEX DOSES, which are likely Sirtex's SIR-Spheres Y-90 resin microspheres used in selective internal radiation therapy (SIRT) to treat inoperable liver tumors and metastatic colorectal cancer. Sirtex has a history of providing these specialized medical devices to federal...
This firm fixed-price purchase order contract was awarded by the Defense Health Agency (DHA) to Sirtex Medical Inc. for the supply of SIR-Spheres Y-90 resin microspheres, a specialized cancer therapy product used for selective internal radiation therapy (SIRT) to treat inoperable primary and metastatic liver tumors, as well as metastatic colorectal cancer to the liver. The contract has a ceiling value of $37,688.00 and a period of performance through September 30, 2024. Sirtex Medical Inc. is...
This is a firm fixed-price contract awarded by the Defense Health Agency (DHA) to Sirtex Medical Inc., a medical device manufacturer specializing in cancer therapies. The $320,000.00 contract is for the supply of SIR-Spheres Y-90 resin microspheres, a targeted radiation therapy technology used to treat liver tumors and metastatic colorectal cancer. The contract has no set-aside designation and supports the provision of specialized medical devices and related materials to the Department of...
This is a $17,750 firm fixed-price definitive contract awarded by the Department of Veterans Affairs (VA) to Sirtex Medical Inc., a for-profit medical device manufacturer. The contract is for the supply of SIR-Spheres Y-90 resin microspheres, a targeted radiation therapy technology used to treat liver tumors and metastatic colorectal cancer. The award has a performance period through February 22, 2023, and is not designated as a set-aside contract. Sirtex Medical Inc. is a global healthcare...
This is a firm fixed-price federal contract award from the Medical Command (MEDCOM) agency of the Department of Defense to Sirtex Medical Inc., a for-profit medical device manufacturer headquartered in Woburn, Massachusetts. The $144,000.00 contract is for the supply of SIR-Spheres Y-90 resin microspheres, a targeted radiation therapy technology used to treat inoperable liver tumors and metastatic colorectal cancer. The contract does not have a set-aside designation. Sirtex Medical has a history...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Sirtex Medical Inc., a global healthcare company, for the supply of SIR-SPHERES Y-90 resin microspheres. The SIR-Spheres are a targeted radiation therapy used in interventional radiology procedures to treat inoperable primary and metastatic liver tumors, as well as metastatic colorectal cancer to the liver, in veterans and military members. The contract has a potential value of $863,760.00 and a completion...
This is a firm fixed-price contract awarded by the Defense Health Agency (DHA) to Sirtex Medical Inc., a for-profit organization headquartered in Woburn, Massachusetts. The contract is for the supply of Y-90 resin microspheres, a specialized radiation therapy technology used to treat liver tumors and metastatic colorectal cancer. The contract has a ceiling value of $138,400.00 and a completion date of May 25, 2022. The contract is not designated as a set-aside. Sirtex Medical Inc. has a...
This is a federal purchase order contract awarded by the Defense Health Agency (DHA) to Sirtex Medical Inc. for the delivery of SIR-Y001 SIR Spheres Y-90 resin microspheres. The $18,345.00 firm fixed-price contract has a period of performance ending on March 31, 2024. The SIR Spheres are used in selective internal radiation therapy to treat inoperable primary and metastatic liver tumors, as well as metastatic colorectal cancer to the liver, in veterans and military members. This contract has...